In The Briefing:
Health Care Workers Approved To Take Psilocybin
Cybin Buys Biotech Company
Tryp Therapeutics To IPO, Field Trip Raises $15m
DMT Approved for UK Trial

In The Briefing: Health Care Workers Approved To Take Psilocybin Cybin Buys Biotech Company Tryp Therapeutics To IPO, Field Trip Raises $15m DMT Approved for UK Trial

The Briefing, December 14th: It's Getting Easier To Trip In Canada

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.

Share The Briefing, December 14th: It's Getting Easier To Trip In Canada

Sign up to save your podcasts

The Briefing, December 14th: It's Getting Easier To Trip In Canada

The Briefing, December 14th: It's Getting Easier To Trip In Canada